CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and can impair differentiation in vivo (2023)

First Author: Saunderson EA
Attributed to:  Elucidating the molecular and epigenetic basis of cancer initiation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Parent Publication: PNAS